QUOTE AND NEWS
Benzinga  May 22  Comment 
According to a research report published this morning, Cantor Fitzgerald has initiated Align Technology (NASDAQ: ALGN) with a Buy rating and $37 PT. In the report, Cantor Fitzgerald said, "With its Invisalign brand of clear aligners, Align has...
Globe Newswire  May 21  Comment 
SAN JOSE, Calif., May 21, 2012 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) today announced that the Company has appointed Tim Mack as senior vice president, marketing and business development, effective immediately. Mr. Mack has served
Market Intelligence Center  May 21  Comment 
Align Technology (NASDAQ:ALGN) closed Friday's negative trading session at $29.72. In the past year, the stock has hit a 52-week low of $14.25 and 52-week high of $34.29. Align Technology (ALGN) stock has been showing support around $28.13 and...
Globe Newswire  May 16  Comment 
SAN JOSE, Calif., May 16, 2012 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) today announced awards of $160,000 in new funding to four universities in North America and four universities internationally, and $60,000 in renewals for a total
PR Newswire  May 8  Comment 
LOS ANGELES, May 8, 2012 /PRNewswire/ -- Having a confident smile is important at any age, even more so when you grow up in the spotlight. And with fans able to interact with celebrities through photos and video on Facebook and Twitter, many young
PR Newswire  May 3  Comment 
CHICAGO, May 3, 2012 /PRNewswire/ -- Zacks Equity Research highlights Align Technology (Nasdaq: ALGN) as the Bull of the Day and Baker Hughes, Inc. (NYSE: BHI) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Research
Globe Newswire  May 3  Comment 
SAN JOSE, Calif., May 3, 2012 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) today announced that Kenneth Arola, Vice President Finance and CFO of Align Technology is scheduled to speak at three upcoming financial conferences. The
Forbes  May 2  Comment 
Align Technology has been on the momentum radar since reporting fourth quarter 2011 earnings of 28 cents, topping the Zacks Consensus Estimate of 22 cents.  EPS results represented a 100% increase over the same period in 2010.
Market Intelligence Center  May 2  Comment 
Align Technology (NASDAQ:ALGN) closed Tuesday's up-and-down trading session at $32.10. In the past year, the stock has hit a 52-week low of $14.25 and 52-week high of $34.29. Align Technology (ALGN) stock has been showing support around $31.03 and...
Globe Newswire  Apr 27  Comment 
SAN JOSE, Calif., April 27, 2012 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) announced today that the United States International Trade Commission (ITC) has completed its review of Align's complaint and voted to institute a formal




RELATED WIKI ARTICLES

Related Articles

 
TOP CONTRIBUTORS

Align Technology, Inc., founded in 1997, is engaged in the design, manufacture, and marketing of Invisalign, a proprietary system for treating malocclusion, or crooked teeth. The Invisalign product has two components, ClinCheck and Aligners. ClinCheck is an Internet-based application that allows dental professionals to simulate treatment in three dimensions, by modeling two-week stages of tooth movement. Aligners are thin, clear-plastic, removable dental appliances that are manufactured in a series to correspond to each two-week stage of the ClinCheck simulation. Aligners are customized to perform the treatment prescribed for an individual patient by dental professionals using ClinCheck. Invisalign is approved to treat patients, with any type of malocclusion, with mature upper and lower tooth structures. The company voluntarily restricts the use of Invisalign to adults and adolescents with immature structures. Typically, permanent structures occur in the later-teen years. Align does not treat children whose teeth and jaws are still developing, as the effectiveness of Invisalign relies on the company's ability to accurately predict the movement of teeth over the course of treatment. Based on its clinical studies to date, Align recommends that dental professionals use Invisalign as a complete treatment for a range of malocclusions, and as a component of treatment for severe malocclusions.


Internationally, the company operates in the regions of Europe, Asia/Pacific, and Latin America. At the end of 2007, sales in the domestic orthodontist channel represented 30% of total revenues, while sales in the domestic general practitioner (GP) channel represented 46%, and the international channel represented 20%. The remaining 5% came from education training and other revenues.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki